Search

Your search keyword '"Burguet, Laure"' showing total 14 results

Search Constraints

Start Over You searched for: Author "Burguet, Laure" Remove constraint Author: "Burguet, Laure"
14 results on '"Burguet, Laure"'

Search Results

2. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

3. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

5. Long-lived central memory γδ T cells confer protection against murine cytomegalovirus reinfection.

6. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

7. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

9. COVID-19 morbidity decreases with tixagevimab–cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders

11. Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis

12. Identification of Predictive Markers and Outcomes of Late-onsetPneumocystis jiroveciiPneumonia in Kidney Transplant Recipients

13. Retrospective study of Aquitaine thrombotic microangiopathy cohort from 2011 to 2017

14. Identification of Predictive Markers and Outcomes of Late-onset Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients.

Catalog

Books, media, physical & digital resources